Coronavirus spike|Coronavirus spike antibody|Coronavirus spike抗体|Anti-2019-nCoV 兔多抗

1, Cai Y, et al. Distinct conformational states of SARS-CoV-2 spike protein.Science (New York, N.Y.), PubMed ID: 32694201
2, Liu R, et al. MVA Vector Vaccines Inhibit SARS CoV-2 Replication in Upper and Lower Respiratory Tracts of Transgenic Mice and Prevent Lethal Disease.bioRxiv : the preprint server for biology, PubMed ID: 33442693
3, Rusanen J, et al. A 10-Minute "Mix and Read" Antibody Assay for SARS-CoV-2.Viruses, PubMed ID: 33498157
4, Park BK, et al. MERS-CoV and SARS-CoV-2 replication can be inhibited by targeting the interaction between the viral spike protein and the nucleocapsid protein.Theranostics, PubMed ID: 33664866
5, Chai KM, et al. DNA vaccination induced protective immunity against SARS CoV-2 infection in hamsterss.PLoS neglected tropical diseases, PubMed ID: 34043618
6, Ao Z, et al. Identification and evaluation of the inhibitory effect of Prunella vulgaris extract on SARS-coronavirus 2 virus entry.PloS one, PubMed ID: 34106944
7, Nguyen NHL, et al. COVID-19 Spike Protein Induced Phononic Modification in Antibody-Coupled Graphene for Viral Detection Application.ACS nano, PubMed ID: 34128653
8, Puthenveetil R, et al. S-acylation of SARS-CoV-2 spike protein: Mechanistic dissection, in vitro reconstitution and role in viral infectivity.The Journal of biological chemistry, PubMed ID: 34428449
9, Lu M, et al. A methyltransferase-defective VSV-based SARS-CoV-2 vaccine candidate provides complete protection against SARS-CoV-2 infection in hamsters.Journal of virology, PubMed ID: 34379509
10, Wu K, et al. One-Step, Wash-free, Nanoparticle Clustering-Based Magnetic Particle Spectroscopy Bioassay Method for Detection of SARS-CoV-2 Spike and Nucleocapsid Proteins in the Liquid Phase.ACS applied materials & interfaces, PubMed ID: 34499464
11, Lam B, et al. In vivo characterization of emerging SARS-CoV-2 variant infectivity and human antibody escape potential.Cell reports, PubMed ID: 34648735
12, Chen J, et al. Sustained Delivery of SARS-CoV-2 RBD Subunit Vaccine Using a High Affinity Injectable Hydrogel Scaffold.Advanced healthcare materials, PubMed ID: 34755476
13, Wang Y, et al. Virucidal effect of povidone-iodine against SARS-CoV-2 in vitro.The Journal of international medical research, PubMed ID: 34914884
14, Kim GN, et al. A vesicular stomatitis virus-based prime-boost vaccination strategy induces potent and protective neutralizing antibodies against SARS-CoV-2.PLoS pathogens, PubMed ID: 34914812
15, Medigeshi GR, et al. Sub-optimal neutralisation of omicron (B.1.1.529) variant by antibodies induced by vaccine alone or SARS-CoV-2 Infection plus vaccine (hybrid immunity) post 6-months.EBioMedicine, PubMed ID: 35305396
16, Slattery SS, et al. Phosphate-regulated expression of the SARS-CoV-2 receptor-binding domain in the diatom Phaeodactylum tricornutum for pandemic diagnostics.Scientific reports, PubMed ID: 35487958
17, Badeti S, et al. Development of a Novel Human CD147 Knock-in NSG Mouse Model to Test SARS-CoV-2 Viral Infection.Research square, PubMed ID: 35475172
18, Singh P, et al. Dynamic Ca2+ sensitivity stimulates the evolved SARS-CoV-2 spike strain-mediated membrane fusion for enhanced entry.Cell reports, PubMed ID: 35397208
19, Zabaleta N, et al. Durable immunogenicity, adaptation to emerging variants, and low-dose efficacy of an AAV-based COVID-19 vaccine platform in macaques.Molecular therapy : the journal of the American Society of Gene Therapy, PubMed ID: 35546782
20, Zhang Q, et al. Induction of neutralizing antibodies against SARS-CoV-2 variants by a multivalent mRNA-lipid nanoparticle vaccine encoding SARS-CoV-2/SARS-CoV Spike protein receptor-binding domains.bioRxiv : the preprint server for biology, PubMed ID: 35547843
21, Ao Z, et al. SARS-CoV-2 Delta spike protein enhances the viral fusogenicity and inflammatory cytokine production.iScience, PubMed ID: 35854977
22, Pszenny V, et al. Using the Sleeping Beauty (SB) Transposon to Generate Stable Cells Producing Enveloped Virus-Like Particles (eVLPs) Pseudotyped with SARS-CoV-2 Proteins for Vaccination.Current protocols, PubMed ID: 36300895
23, Meng W, et al. Development and characterization of a new monoclonal antibody against SARS-CoV-2 NSP12 (RdRp).Journal of medical virology, PubMed ID: 36271490
24, Zhao H, et al. Detection of SARS-CoV-2 antibodies in serum and dried blood spot samples of vaccinated individuals using a sensitive homogeneous proximity extension assay.New biotechnology, PubMed ID: 36423830
25, Zhang H, et al. Virologica Sinica, PubMed ID: 36587795
26, Azevedo PO, et al. Differential requirement of neutralizing antibodies and T cells on protective immunity to SARS-CoV-2 variants of concern.NPJ vaccines, PubMed ID: 36781862
27, Radovic S, et al. SARS-CoV-2 infection of kidney tissues from severe COVID-19 patients.Journal of medical virology, PubMed ID: 36756942
28, Xia S, et al. SARS-CoV-2 Omicron subvariants exhibit distinct fusogenicity, but similar sensitivity, to pan-CoV fusion inhibitors.Emerging microbes & infections, PubMed ID: 36748716
29, Ham Y, et al. The SpACE-CCM: A facile and versatile cell culture medium-based biosensor for detection of SARS-CoV-2 spike-ACE2 interaction.Biosensors & bioelectronics, PubMed ID: 36827795
30, Xia S, et al. SARS-CoV-2 Omicron XBB subvariants exhibit enhanced fusogenicity and substantial immune evasion in elderly population, but high sensitivity to pan-coronavirus fusion inhibitors.Journal of medical virology, PubMed ID: 36890632
31, Sormunen A, et al. Comparison of Automated and Traditional Western Blotting Methods.Methods and protocols, PubMed ID: 37104025
32, Zhang Y, et al. Comparison of the immunogenicity of nasal-spray rVSV vector, adenovirus vector, and inactivated COVID-19-based vaccines in rodent models.Journal of medical virology, PubMed ID: 37219050
33, McConnell SA, et al. Spike-protein proteolytic antibodies in COVID-19 convalescent plasma contribute to SARS-CoV-2 neutralization.Cell chemical biology, PubMed ID: 37354908
34, Wang Z, et al. Anthracyclines inhibit SARS-CoV-2 infection.Virus research, PubMed ID: 37379907
35, Li Y, et al. A micro-electroporation/electrophoresis-based vaccine screening system reveals the impact of vaccination orders on cross-protective immunity.iScience, PubMed ID: 37860767
36, Lusvarghi S, et al. Effects of N-glycan modifications on spike expression, virus infectivity, and neutralization sensitivity in ancestral compared to Omicron SARS-CoV-2 variants.PLoS pathogens, PubMed ID: 37943965
37, Roy AV, et al. Quercetin inhibits SARS-CoV-2 infection and prevents syncytium formation by cells co-expressing the viral spike protein and human ACE2.Virology journal, PubMed ID: 38273400
38, Xing M, et al. An intranasal combination vaccine induces systemic and mucosal immunity against COVID-19 and influenza.NPJ vaccines, PubMed ID: 38509167
39, Zhang Q, et al. Induction of neutralizing antibodies against SARS-CoV-2 variants by a multivalent mRNA-lipid nanoparticle vaccine encoding SARS-CoV-2/SARS-CoV Spike protein receptor-binding domains in mice.PloS one, PubMed ID: 38635805
40, Huang J, et al. Antiviral research, PubMed ID: 38740191